Blood-Based Inflammatory Biomarkers: A Literature Review

Penulis

  • Zahara Nurfatihah Z Universitas Lampung
  • Ghea Farmaning Thias Putri Universitas Sultan Ageng Tirtayasa
  • Elsa Septiani Putri Universitas Halu Oleo

DOI:

https://doi.org/10.63004/hrji.v4i5.1096

Kata Kunci:

biomarkers, blood-based biomarkers, inflammation

Abstrak

Introduction: Inflammation is a fundamental biological response involved in the development and progression of various diseases and is commonly assessed using indicators detected in blood. A wide range of inflammatory biomarkers has been described. However, differences in their biological characteristics and clinical relevance require clear understanding for appropriate use. Objective: This review aims to summarize the blood-based inflammatory biomarkers and to present a clear description of their characteristics, strengths, and limitations, as well as key concepts related to their clinical application and interpretation as indicators of inflammatory activity. Method: This study was conducted as a literature review using secondary data from scientific publications. Articles published within the last five years were identified from PubMed, Scopus, and Google Scholar and selected based on their relevance to blood-based inflammatory biomarkers and the clarity of reported information. The selected literature, consisting of original research articles and review papers, was analyzed descriptively to synthesize and compare findings across studies. Result: The results indicate that blood-based inflammatory biomarkers can be grouped into several main categories, each reflecting different mechanisms and stages of inflammation. Differences in biological function and applicability were observed among biomarker groups, highlighting variations in their usefulness depending on inflammatory context. Conclusion: Blood-based inflammatory biomarkers provide important information for evaluating inflammatory status. Accurate assessment depends on interpretation that accounts for biological function, inflammatory context, and inherent limitations of each biomarker.

Unduhan

Data unduhan belum tersedia.

Referensi

Al-qahtani, A. A., Alhamlan, F. S., & Al-qahtani, A. A. (2024). Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases : A Comprehensive Review. Tropical Medicine and Infectious Disease, 9(1), 13.

Barichello, T., Generoso, J. S., Singer, M., & Pizzol, F. D. (2022). Biomarkers for sepsis : more than just fever and leukocytosis — a narrative review. Critical Care, 26(1), 14. https://doi.org/10.1186/s13054-021-03862-5

Belvederi F, Leggeri S, Urbani A, B. S. (2025). suPAR as a biomarker of support in different clinical settings. Clinica Chimica Acta, 573, 120303.

Bettcher, B. M., Oliveira, F. F. De, Willette, A. A., Michalowska, M. M., Machado, L. S., Rajbanshi, B., Borelli, W. V, Tansey, M. G., Rocha, A., Suryadevara, V., & Hu, W. T. (2025). Analysis and interpretation of inflammatory fluid markers in Alzheimer ’ s disease : a roadmap for standardization. Journal of Neuroinflammation, 22(1), 105.

Bruserud, Ø., Aarstad, H. H., Henrik, T., & Tvedt, A. (2020). Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer — What Can We Learn from the Hematological Experience ? Cancers, 12(7), 1966.

Buonacera, A., Stancanelli, B., Colaci, M., & Malatino, L. (2022). Neutrophil to Lymphocyte Ratio : An Emerging Marker of the Relationships between the Immune System and Diseases. International Journal of Molecular Sciences, 23(7), 3636.

Callaghan, K. M. O., & Roth, D. E. (2020). Standardization of laboratory practices and reporting of biomarker data in clinical nutrition research. The American Journal of Clinical Nutrition, 112, 453S-457S. https://doi.org/10.1093/ajcn/nqaa036

Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023). The multifaceted nature of IL-10 : regulation , role in immunological homeostasis and its relevance to cancer , COVID-19 and post-COVID conditions. Frontiers in Immunology, 14, 1161067. https://doi.org/10.3389/fimmu.2023.1161067

Chambliss, A. B., Patel, K., Colón-franco, J. M., & Hayden, J. (2023). AACC Guidance Document on the Clinical Use of Procalcitonin. The Journal of Applied Laboratory Medicine, 8(3), 598–634. https://doi.org/10.1093/jalm/jfad007

Chen, K., Sun, H., Geng, Y., Yang, C., Shan, C., & Chen, Y. (2023). Ferritin and procalcitonin serve as discriminative inflammatory biomarkers and can predict the prognosis of severe fever with thrombocytopenia syndrome in its early stages. Frontiers in Microbiology, 14, 1168381.

Chen, R., Chen, Q., Zheng, J., Zeng, Z., Chen, M., Li, L., & Zhang, S. (2023). Serum amyloid protein A in in fl ammatory bowel disease : from bench to bedside. Cell Death Discovery, 9(1), 154. https://doi.org/10.1038/s41420-023-01455-5

Choucair, K., Nebhan, C., Cortellini, A., Hentzen, S., Wang, Y., Liu, C., Giusti, R., Filetti, M., Ascierto, P. A., Vanella, V., Galetta, D., Catino, A., Al-bzour, N., Saeed, A., Cavalcante, L., Pizzutilo, P., Genova, C., Bersanelli, M., Buti, S., … Naqash, A. R. (2023). Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Surviva. Cancers, 15(20), 5052.

Cosma-l, R., Leucuta, D., & Popoviciu, M. (2025). Systemic Immune-Inflammation Index and Related Hematologic Markers as Prognostic Tools in Type 2 Diabetes. Medicina, 61(8), 1433.

Damme, J. Van, Struyf, S., Proost, P., & Opdenakker, G. (2025). Functional Interactions Between Recombinant Serum Amyloid A1 ( SAA1 ) and Chemokines in Leukocyte Recruitment. Journal of Molecular Sciences, 26(5), 2258.

Ehlting, C., Wolf, S. D., & Bode, J. G. (2021). Acute-phase protein synthesis : a key feature of innate immune functions of the liver. Biological Chemistry, 402(9), 1129–1145.

Engelmaier, A., Zimmermann, M., Butterweck, H. A., & Weber, A. (2025). Bioanalytical Method Validations of Three Alpha1-Antitrypsin Measurement Methods Required for Clinical Sample Analysis. Pharmaceuticals, 18(8), 1165.

Fabris, M., Ben, F. Del, Sozio, E., Beltrami, A. P., Cif, A., Bertolino, G., Caponnetto, F., Cotrufo, M., Tascini, C., & Curcio, F. (2022). Cytokines from Bench to Bedside : A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients. Nternational Journal of Molecular Sciences, 23(9), 4830.

Fasulkov, I., Karadaev, M., Zapryanova, D., Mircheva, T., Vasilev, N., Ceciliani, F., Disorders, R., Zagora, S., Physiology, A., Chemistry, P., & Zagora, S. (2022). Comparative Study on Plasma Fibrinogen and Ceruloplasmin Concentrations During Pregnancy and Postpartum Period in Bulgarian Native Goats. Bulgarian Journal of Veterinary Medicine, 25(4), 603–612. https://doi.org/10.15547/bjvm.2372

Fung, E., Chan, E. Y. S., Ng, K. H., Yu, K. M., Li, H., & Wang, Y. (2023). Towards clinical application of GlycA and GlycB for early detection of inflammation associated with ( pre ) diabetes and cardiovascular disease : recent evidence and updates. Journal of Inflammation, 20(1), 32. https://doi.org/10.1186/s12950-023-00358-7

Garlanda, C., Ceglie, I. Di, & Jaillon, S. (2025). IL-1 family cytokines in in fl ammation and immunity. Cellular & Molecular Immunology, 22(11), 1345–1362. https://doi.org/10.1038/s41423-025-01358-8

Gautreaux, M., Tucker, L., Person, X., Zetterholm, H., & Priddy, L. (2022). Review of immunological plasma markers for longitudinal analysis of inflammation and infection in rat models. Journal of Orthopaedic Research, 40, 1251–1262.

Germolec, D. R., Shipkowski, K. A., Frawley, R. P., & Evans, E. (2018). Markers of Inflammation. Humana Press.

Hadžimusić, N., & Hadžijunuzović-Alagić, D. (2025). MEDIATORS OF THE ACUTE PHASE RESPONSE : THE ROLE OF CYTOKINES. International Journal of Agriculture and Environmental Research, 11(2), 337–350.

Hamidullah, Ali, S., Imranullah, & Ahmad, I. (2025). Investigating fibrinogen levels as a biomarker for immune inflammation severity in COPD patients across GOLD stages. The Journal of the Pakistan Medical Association, 75(4), 556–563.

Hartigh, L. J. Den, May, K. S., Zhang, X., Chait, A., & Blaser, martin j. (2023). Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions. Rontiers in Cardiovascular Medicine, 10, 1197432. https://doi.org/10.3389/fcvm.2023.1197432

Inamdar, A., Bugadannavar, P., Palled, M., Umarani, S., & Salve, P. (2025). Biological determinants of blood-based biomarker levels in Alzheimer ’ s disease : role of nutrition , inflammation , and metabolic factors. Frontiers in Aging Neuroscience, 17, 1614962. https://doi.org/10.3389/fnagi.2025.1614962

Iordache, M. P., Buliman, A., Costea-firan, C., Claudiu, T., Gligore, I., & Blendea, C. (2025). Immunological and Inflammatory Biomarkers in the Prognosis , Prevention , and Treatment of Ischemic Stroke : A Review of a Decade of Advancement. International Journal of Molecular Sciences, 26(16), 1–21.

Islam, M. M., Satici, M. O., & Eroglu, S. E. (2024). Unraveling the clinical significance delta neutrophil index : An extensive literature review. Turkish Journal of Emergency Medicine, 24(1), 8–19. https://doi.org/10.4103/tjem.tjem

Jarlborg, M., & Gabay, C. (2022). Cytokine Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints. Cytokine, 149, 155742. https://doi.org/10.1016/j.cyto.2021.155742

Jiers, W., Sommerfeld-klatta, K., Gumustas, M., Mozdziak, P., Zaba, C., Łukasik-gł, M., Te, A., & Zaba, Z. (2025). Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs. Pharmaceuticals, 18(8), 1213.

Kourilovitch, M., & Maldonado, C. G. (2022). Could a simple biomarker as neutrophil-to-lymphocyte ratio reflect complex processes orchestrated by neutrophils? Journal of Translational Autoimmunity, 6, 100159. https://doi.org/10.1016/j.jtauto.2022.100159

Kumar, N. P., Rajamariyam, M., Nancy, A., Kumar, B. S., Janakiram, M., Ahamed, S. F., Kumar, V., Vijila, S., Sekar, S., Kuralmozhi, R., Baskaran, D., Hissar, S., & Babu, S. (2025). Acute-phase proteins as biomarkers of in fl ammation in HIV patients with latent tuberculosis : a prospective study. Frontiers in Immunology, 16, 1551775. https://doi.org/10.3389/fimmu.2025.1551775

Laudisio, D., Alteriis, G. De, Vetrani, C., Aprano, S., Pugliese, G., Zumbolo, F., Colao, A., & Savastano, S. (2023). Iron Levels and Markers of Inflammation in a Population of Adults with Severe Obesity, a Cross-Sectional Study. Nutrients, 15(21), 4720.

Liang, H., & Xu, J. (2025). Th17-related cytokines and chemokines are associated with immune dysregulation and severity in schizophrenia. Frontiers in Psychiatry, 16, 1675129. https://doi.org/10.3389/fpsyt.2025.1675129

Libby, P. (2021). argeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells, 10(4), 951.

Liu, C., Chu, D., Kalantar-zadeh, K., George, J., & Young, H. A. (2021). Cytokines : From Clinical Significance to Quantification. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 8(15), e2004433. https://doi.org/10.1002/advs.202004433

Liu, K., Yang, L., & Liu, Y. (2025). Systemic Immune-Inflammation Index ( SII ) and Neutrophil-to-Lymphocyte Ratio ( NLR ): A Strong Predictor of Disease Severity in Large-Artery Atherosclerosis ( LAA ) Stroke Patients. Journal of Inflammation Research, 18, 195–202.

Liu, Y., Guan, S., Xu, H., Zhang, N., Huang, M., & Liu, Z. (2023). Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Frontiers in Cardiovascular Medicine, 10, 1175174. https://doi.org/10.3389/fcvm.2023.1175174

Lodge, S., Masuda, R., Nitschke, P., Beilby, J. P., Hui, J., Hunter, M., Litton, E., Raby, E., Currie, A., Yeap, B. B., Millet, O., Cannet, C., Schaefer, H., Spraul, M., Holmes, E., Wist, J., & Nicholson, J. K. (2025). NMR Spectroscopy-Based Lipoprotein and Glycoprotein Biomarkers Differentiate Acute and Chronic Inflammation in Diverse Healthy and Disease Population Cohorts. Journal of Proteome Research, 24(8), 4191–4201. https://doi.org/10.1021/acs.jproteome.5c00300

Long, L., Tao, Y., Yu, W., Hou, Q., Liang, Y., Huang, K., Luo, H., & Yi, B. (2025). Multiparameter diagnostic model using S100A9 , CCL5 and blood biomarkers for nasopharyngeal carcinoma. Scientific Reports, 15(1), 7502.

Maamar, M., Artime, A., Pariente, E., Fierro, P., Ruiz, Y., Gutiérrez, S., Tobalina, M., Díaz-Salazar, S., Ramos, C., Olmos, J., & Hernández, J. (2022). Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Current Medical Research and Opinion, 1–9.

Mallagaray, A., Rudolph, L., Lindloge, M., Mölbitz, J., Thomsen, H., Schmelter, F., Alhabash, M. W., Abdullah, M. R., Saraei, R., Ehlers, M., Graf, T., Sina, C., Petersmann, A., Nauck, M., & Günther, U. L. (2023). Towards a Precise NMR Quantification of Acute Phase Inflammation Proteins from Human Serum Angewandte. Angewandte Chemie (International Ed. in English), 62(35), e202306154. https://doi.org/10.1002/anie.202306154

Megha, K. B., Joseph, X., Akhil, V., & Mohanan, P. V. (2021). Cascade of immune mechanism and consequences of inflammatory disorders. International Journal of Phytotherapy and Phytopharmacology, 91, 153712. https://doi.org/10.1016/j.phymed.2021.153712

Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T. (2021). Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice — Which to Use Regarding Disease Outcomes ? Antioxidants, 10(3), 414.

Moreno-guerrero, S. S., Ramírez-pacheco, A., Rocha-ramírez, L. M., Hernández-pliego, G., Reyes-lópez, A., Sienra-monge, J. J. L., & Juárez-villegas, L. E. (2025). Analysis of Pro-Inflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Pediatric Patients with Neuroblastoma : A Preliminary Study. Biomedicines, 13(7), 1517.

Murayama, M. A., Shimizu, J., Miyabe, C., Yudo, K., & Miyabe, Y. (2023). Chemokines and chemokine receptors as promising targets in rheumatoid arthritis. Frontiers in Immunology, 14, 1100869. https://doi.org/10.3389/fimmu.2023.1100869

O’Donnell, T., Weinstein, S., Yano, Y., Albert, P., Black, A., Brotzman, M., Diaz-Mayoral, N., Shreves, A., Gerlanc, N., Wyatt, K., Gaudet, M., Abnet, C., & Wentzensen, N. (2025). The Effect of Preanalytical Conditions on Blood-Based Inflammation Biomarkers. Journal of Proteome Research.

Pah, A., Serban, S., Mateescu, D., Cotet, I., Muresan, C., Ilie, A., Buleu, F., Craciun, M., Crisan, S., & Avram, A. (2025). Systemic Inflammatory Biomarkers ( Interleukin-6 , High-Sensitivity C-Reactive Protein , and Neutrophil-to-Lymphocyte Ratio ) and Prognosis in Heart Failure : A Meta-Analysis of Prospective Cohort Studies. Journal of Clinical Medicine, 14(23), 8610.

Pansini, I., Galli, E., Corrente, A., Viscovo, M., Baroni, S., Piccirillo, N., Chiusolo, P., Sor, F., & Sica, S. (2025). Tracking Inflammation in CAR-T Therapy : The Emerging Role of Serum Amyloid A ( SAA ). Cancers, 17, 3184.

Pepys, M. B. (2021). C-reactive protein predicts outcome in COVID-19 : is it also a therapeutic target ? 2280–2283. https://doi.org/10.1093/eurheartj/ehab169

Pournaghi, S. J., Jamialahmadi, H., Pazhohan-Nezhad, H., Moghbeli, M., Saburi, A., Eghbal, F., Nakhlband, A., & Saburi, E. (2024). (2024). Procalcitonin in inflammatory bowel disease: A diagnostic or prognostic marker. Pathology, Research and Practice, 262, 155548.

Pritzker, K. (2023). Blood-based biomarkers of chronic inflammation. Expert Review of Molecular Diagnostics, 23, 495–504.

Radonjic-Hoesli, S., Pavlov, N., Simon, H. U., & Simon, D. (2022). Are blood cytokines reliable biomarkers of allergic disease diagnosis and treatment responses? The Journal of Allergy and Clinical Immunology, 150(2), 251–258.

Raju, V., Reddy, R., Cyrus, A., Hajihossainlou, B., Weissleder, R., Guiseppi-elie, A., Kurabayashi, K., Jones, S. A., & Faghih, R. T. (2025). Tracking inflammation status for improving patient prognosis : A review of current methods , unmet clinical needs and opportunities. Biotechnology Advances, 82, 108592. https://doi.org/10.1016/j.biotechadv.2025.108592

Rasmussen, L. J. H., Petersen, J. E. V, & Eugen-Olsen, J. (2021). Soluble Urokinase Plasminogen Activator Receptor ( suPAR ) as a Biomarker of Systemic Chronic In fl ammation. Frontiers in Immunology, 12, 1–22. https://doi.org/10.3389/fimmu.2021.780641

Reschke, R., Enk, A. H., & Hassel, J. C. (n.d.). Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors : From Biomarkers to Therapeutic Targets. International Journal of Molecular Sciences, 25(12), 6532.

Rizo-tellez, S. A., Sekheri, M., & Filep, J. G. (2023). C-reactive protein : a target for therapy to reduce in fl ammation. Frontiers in Immunology, 14, 1237729. https://doi.org/10.3389/fimmu.2023.1237729

Schuetz, P. (2022). How to best use procalcitonin to diagnose infections and manage antibiotic treatment. Clinical Chemistry and Laboratory Medicine, 61(5), 822–828.

Sorić Hosman, I., Kos, I., & Lamot, L. (2021). Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker. Frontiers in Immunology, 11, 631299.

Speeckaert, R., Belpaire, A., Speeckaert, M. M., & Geel, N. Van. (2023). A meta-analysis of chemokines in vitiligo : Recruiting immune cells towards melanocytes. Frontiers in Immunology, 14, 1112811. https://doi.org/10.3389/fimmu.2023.1112811

Vanderkamp, S. G., Niazy, M., Stegelmeier, A. A., Stinson, K. J., Ricker, N., & Bridle, B. W. (2025). Cytokine, chemokine, and acute-phase protein profiles in plasma as correlative biomarkers of clinical outcomes for patients with COVID-19. Scie, 15, 15397.

Vasbinder, A., Padalia, K., Pizzo, I., Machado, K., Catalan, T., Presswalla, F., Anderson, E., Ismail, A., Berlin, H., Huang, Y., Blakely, P., Meloche, C., Michaud, E., Hayer, P. O., Pan, M., Shadid, H. R., Jee, L., Rasmussen, H., Roberts, D. A., … Hayek, S. S. (2024). SuPAR , biomarkers of inflammation , and severe outcomes in patients hospitalized for COVID ‐ 19 : The International Study of Inflammation in COVID ‐ 19. Journal of Medical Virology, 96(1), e29389. https://doi.org/10.1002/jmv.29389

Visser, K., Koggel, M., Blaauw, J., Jan, H., Horn, V. Der, & Jacobs, B. (2022). Blood-based biomarkers of inflammation in mild traumatic brain injury : A systematic review. Neuroscience and Biobehavioral Reviews, 132(June 2021), 154–168. https://doi.org/10.1016/j.neubiorev.2021.11.036

Walzik, D., Joisten, N., Zacher, J., & Zimmer, P. (2021). Transferring clinically established immune inflammation markers into exercise physiology : focus on neutrophil ‑ to ‑ lymphocyte ratio , platelet ‑ to ‑ lymphocyte ratio and systemic immune ‑ inflammation index. European Journal of Applied Physiology, 121(7), 1803–1814. https://doi.org/10.1007/s00421-021-04668-7

Wang, R., Wen, W., Jiang, Z., Du, Z.-P., Ma, Z.-H., Lu, A.-L., Li, H.-P., Yuan, F., Wu, S.-B., Guo, J.-W., Cai, Y.-F., Huang, Y., Wang, L.-X., & Lu, H.-J. (2023). The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients wi. Frontiers in Immunology, 14, 1115031. https://doi.org/10.3389/fimmu.2023.1115031

Wei, Y., Wang, T., Li, G., Feng, J., Deng, L., Xu, H., Yin, L., Ma, J., Chen, D., & Chen, J. (2022). Investigation of systemic immune-inflammation index , lipoprotein ratio , lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder. Frontiers in Psychiatry, 13, 941728. https://doi.org/10.3389/fpsyt.2022.941728

Wei, Z., Chen, Y., Dong, P., Liu, Z., Lai, X., Wang, N., Li, H., Wang, Q., & Tao, L. (2024). CXCL9 / CXCL10 as biomarkers the monitoring of treatment responses in Pulmonary TB patients : a systematic review and meta- analysis. BMC Infectious Diseases, 24(1), 1037.

Wunderle, C., Martin, E., Wittig, A., Tribolet, P., Lutz, T. A., Köster-Hegmann, C., Stanga, Z., Mueller, B., & Schuetz, P. (2025). Comparison of the inflammatory biomarkers IL- 6, TNF-α, and CRP to predict the effect of nutritional therapy on mortality in medical patients at risk of malnutrition : A secondary analysis of the randomized clinical trial EFFORT. Journal of Inflammation, 22(1), 16.

Xingxing Liu, Guo, Y., & Qi, W. (2025). Prognostic value of composite inflammatory markers in patients with chronic obstructive pulmonary disease : A retrospective cohort study based on the MIMIC-IV database. PLOS ONE, 20(1), e0316390. https://doi.org/10.1371/journal.pone.0316390

Yameny, A. A. (2025). A. (2025). IL-6, TNF-α, IL-1β, and IFN-γ Cytokines as Core Inflammatory Biomarkers: Biological Roles, Diagnostic Utility, and Clinical Applications. Journal of Bioscience and Applied Research, 11(3), 1055–1061.

Yao, W., Wang, W., Tang, W., Lv, Q., & Ding, W. (2023). Neutrophil ‑ to ‑ lymphocyte ratio ( NLR ), platelet ‑ to ‑ lymphocyte ratio ( PLR ), and systemic immune inflammation index ( SII ) to predict postoperative pneumonia in elderly hip fracture patients. Journal of Orthopaedic Surgery and Research, 18(1), 673. https://doi.org/10.1186/s13018-023-04157-x

Yin, Y., Li, Y., Zhang, Y., Jia, Q., Tang, H., Chen, J., & Ji, R. (2024). CXCL8 may serve as a potential biomarker for predicting the prognosis and immune response in cervical cancer. Discover Oncology, 15(1), 601. https://doi.org/10.1007/s12672-024-01475-2

Zheng, Z. Q., Yuan, G. Q., Zhang, G. G., Chen, Y. T., Nie, Q. Q., & Wang, Z. (2023). Identification of CCL20 as a Key Biomarker of Inflammatory Responses in the Pathogenesis of Intracerebral Hemorrhage. Inflammation, 46(4), 1290–1304.

Unduhan

Diterbitkan

01-06-2026

Cara Mengutip

Nurfatihah Z, Z., Putri, G. F. T., & Putri, E. S. (2026). Blood-Based Inflammatory Biomarkers: A Literature Review. Health Research Journal of Indonesia, 4(5), 449–460. https://doi.org/10.63004/hrji.v4i5.1096

Terbitan

Vol 4 No 5 (2026): Health Research Journal of Indonesia

Bagian

Artikel

Lisensi

Karya belum pernah diterbitkan sebelumnya (kecuali dalam bentuk abstrak atau bagian dari kuliah atau tesis yang diterbitkan) dan tidak sedang dipertimbangkan untuk diterbitkan di tempat lain. Ketika naskah diterima untuk diterbitkan dalam jurnal ini, penulis setuju untuk mentransfer hak cipta secara otomatis ke penerbit.

Lisensi Creative Commons
Health Research Journal of Indonesia dilisensikan di bawah Creative Commons Attribution-NonCommercial 4.0 International License